Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (9): 872-879.doi: 10.19982/j.issn.1000-6621.20230115
• Original Articles • Previous Articles Next Articles
Li Yamin, Gao Zhidong(), Li Yanyuan, Tao Liying, Zhao Xin
Received:
2023-04-14
Online:
2023-09-10
Published:
2023-09-01
Contact:
Gao Zhidong, Email: Supported by:
CLC Number:
Li Yamin, Gao Zhidong, Li Yanyuan, Tao Liying, Zhao Xin. Effectiveness of WeChat and electronic pillbox in strengthening supervision management for pulmonary tuberculosis patients in Beijing[J]. Chinese Journal of Antituberculosis, 2023, 45(9): 872-879. doi: 10.19982/j.issn.1000-6621.20230115
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20230115
治疗时间 | 微信 | 电子药盒 | 合计 | ||||||
---|---|---|---|---|---|---|---|---|---|
服药次数 | 打卡次数 | 打卡率(%) | 服药次数 | 打卡次数 | 打卡率(%) | 服药次数 | 打卡次数 | 打卡率(%) | |
疗程开始时 | 134 | 134 | 100.0 | 381 | 381 | 100.0 | 515 | 515 | 100.0 |
1周末 | 938 | 754 | 80.4 | 2667 | 2222 | 83.3 | 3605 | 2976 | 82.6 |
2周末 | 1862 | 1435 | 77.1 | 5334 | 4357 | 81.7 | 7196 | 5792 | 80.5 |
1个月末 | 3990 | 2901 | 72.7 | 11340 | 8963 | 79.0 | 15330 | 11864 | 77.4 |
2个月末 | 7860 | 5502 | 70.0 | 22440 | 16193 | 72.2 | 30330 | 21725 | 71.6 |
3个月末 | 11700 | 7773 | 66.4 | 33390 | 22251 | 66.6 | 45090 | 30024 | 66.6 |
4个月末 | 15360 | 9641 | 62.8 | 44040 | 27437 | 62.3 | 59400 | 37078 | 62.4 |
5个月末 | 19050 | 11185 | 58.7 | 54750 | 31738 | 58.0 | 73800 | 42923 | 58.2 |
6个月末 | 22140 | 12249 | 55.3 | 60300 | 34083 | 56.5 | 82440 | 46332 | 56.2 |
7个月末 | 20160 | 11308 | 56.1 | 51240 | 28552 | 55.7 | 71400 | 39860 | 55.8 |
8个月末 | 21840 | 12060 | 55.2 | 49200 | 25709 | 52.3 | 71040 | 37769 | 53.2 |
疗程结束 | 37303 | 17049 | 45.7 | 101610 | 46173 | 45.4 | 138913 | 63222 | 45.5 |
Z值 | -62.182 | -117.843 | -133.070 | ||||||
P值 | <0.001 | <0.001 | <0.001 |
变量名称 | 赋值 | 变量名称 | 赋值 |
---|---|---|---|
因变量 | 未规则打卡=0;规则打卡=1 | 诊断结果 | 病原学阳性=1;病原学阴性=2;无病原学结果=3;结核性胸膜炎=4 |
自变量 | |||
治疗分类 | 初治=1;复治=2 | ||
性别 | 男=1;女=2 | ||
并发症 | 无=0;有=1 | ||
年龄 | 18~30岁=1;30~60岁=2;≥60岁=3 | ||
合并其他结核 | 无=0;有=1 | ||
民族 | 汉族=1;少数民族=2 | ||
职业 | 在职人员=1;离退人员=2;农牧渔民=3;学生=4;家务及待业人员=5 | ||
就诊时间 | 定量资料,从出现症状到就诊的时间 | ||
确诊时间 | 定量资料,从就诊到确诊的时间 | ||
户籍 | 外地=1;北京市=2 | ||
智能工具类型 | 微信=1;电子药盒=2 | ||
首诊单位性质 | 市级定点=1;区级定点=2;结核病防治机构=3 |
因素 | 规则打卡 | 未规则打卡 | 合计 | 统计检验值 | P值 |
---|---|---|---|---|---|
性别[例(构成比,%)] | χ2=0.391 | 0.532 | |||
男性 | 80(24.2) | 251(75.8) | 331 | ||
女性 | 40(21.7) | 144(78.3) | 184 | ||
年龄 [例(构成比,%)] | χ2=18.726 | <0.001 | |||
<30岁 | 21(12.2) | 151(87.8) | 172 | ||
30~60岁 | 68(30.5) | 155(69.5) | 223 | ||
≥60岁 | 31(25.8) | 89(74.2) | 120 | ||
职业[例(构成比,%)] | χ2=18.704 | <0.001 | |||
在职人员 | 44(19.9) | 177(80.1) | 221 | ||
离退人员 | 9(14.1) | 55(85.9) | 64 | ||
农牧渔民 | 31(39.7) | 47(60.3) | 78 | ||
学生 | 2(10.0) | 18(90.0) | 20 | ||
家务及待业 | 34(25.8) | 98(74.2) | 132 | ||
户籍[例(构成比,%)] | χ2=10.115 | 0.002 | |||
北京市 | 69(29.9) | 162(70.1) | 231 | ||
外地 | 51(18.0) | 233(82.0) | 284 | ||
民族[例(构成比,%)] | -a | 0.628a | |||
汉族 | 118(23.2) | 391(76.8) | 509 | ||
少数民族 | 2(33.3) | 4(66.7) | 6 | ||
首诊单位性质[例(构成比,%)] | χ2=31.001 | <0.001 | |||
市级定点 | 63(24.8) | 191(75.2) | 254 | ||
区级定点 | 13(76.5) | 4(23.5) | 17 | ||
结核病防治机构 | 44(18.0) | 200(82.0) | 244 | ||
诊断结果[例(构成比,%)] | χ2=6.658 | 0.084 | |||
病原学阳性 | 69(25.6) | 201(74.4) | 270 | ||
病原学阴性 | 34(19.3) | 142(80.7) | 176 | ||
无病原学结果 | 12(35.3) | 22(64.7) | 34 | ||
结核性胸膜炎 | 5(14.3) | 30(85.7) | 35 | ||
治疗分类[例(构成比,%)] | χ2=0.001 | 0.982 | |||
初治 | 116(23.3) | 382(76.7) | 498 | ||
复治 | 4(23.5) | 13(76.5) | 17 | ||
并发症[例(构成比,%)] | χ2=0.431 | 0.512 | |||
无 | 104(22.9) | 351(77.1) | 455 | ||
有 | 16(26.7) | 44(73.3) | 60 | ||
合并其他结核[例(构成比,%)] | χ2=9.631 | 0.002 | |||
无 | 90(20.8) | 343(79.2) | 433 | ||
有 | 30(36.6) | 52(63.4) | 82 | ||
就诊时间[d,M(Q1,Q3)] | 4(0,27) | 2(0,23) | 3(0,24) | Z=-1.517 | 0.129 |
确诊时间[d,M(Q1,Q3)] | 7(0,17.5) | 7(0,16) | 7(0,16) | Z=-0.871 | 0.384 |
智能工具类型[例(构成比,%)] | χ2=0.586 | 0.444 | |||
微信 | 28(20.9) | 106(79.1) | 134 | ||
电子药盒 | 92(24.1) | 289(75.9) | 381 |
[1] | World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization, 2022. |
[2] | 北京市卫生健康委信息中心, 北京市卫生健康大数据与政策研究中心. 2021年北京市卫生健康事业发展统计公报[EB/OL]. [2022-02-01]. http://www.phic.org.cn/tjsj/wstjgb/202203/P020220316647704704042.pdf. |
[3] | 中华人民共和国国家卫生和计划生育委员会. 国家卫生计生委关于印发《国家基本公共卫生服务规范(第三版)》的通知. 国卫基层发〔2017〕13号. 2017-02-28. |
[4] | 北京市卫生健康委办公室. 北京市卫生健康委员会关于印发北京市结核病防治工作规范(2020年版)的通知. 京卫疾控〔2020〕71号. 2020-09-09. |
[5] |
李雪, 姜世闻, 胡冬梅, 等. 电子药盒和手机微信APP的应用对肺结核患者服药依从性的效果评价. 中国防痨杂志, 2019, 41(9): 957-961. doi:10.3969/j.issn.1000-6621.2019.09.009.
doi: 10.3969/j.issn.1000-6621.2019.09.009 |
[6] |
李亚敏, 高志东, 陈曦, 等. 移动互联网技术用于社区肺结核患者健康管理的接受意愿调查分析. 中国防痨杂志, 2020, 42(12): 1313-1317. doi:10.3969/j.issn.1000-6621.2020.12.012.
doi: 10.3969/j.issn.1000-6621.2020.12.012 |
[7] |
王倪, 张慧, 张铁娟, 等. 使用电子药盒辅助肺结核患者服药管理的实施情况分析. 中国防痨杂志, 2020, 42(7): 682-686. doi:10.3969/j.issn.1000-6621.2020.07.008.
doi: 10.3969/j.issn.1000-6621.2020.07.008 |
[8] |
杨帆, 马建军, 高迎, 等. 吉林省结核病患者全面推广电子药盒后的使用率及影响因素分析. 中国防痨杂志, 2022, 44(10): 1050-1056. doi:10.19982/j.issn.1000-6621.20220080.
doi: 10.19982/j.issn.1000-6621.20220080 |
[9] |
李勇, 路丽苹, 李瑾, 等. 肺结核患者对结核助手APP和电子药盒的使用意愿和效果分析. 结核与肺部疾病杂志, 2022, 3(1): 22-26. doi:10.19983/j.issn.2096-8493.20210110.
doi: 10.19983/j.issn.2096-8493.20210110 |
[10] | 中华人民共和国国家卫生和计划生育委员会. WS 196—2017结核病分类. 2017-11-09. |
[11] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09. |
[12] | World Health Organization. Guidelines for drug susceptible tuberculosis and patient care. Geneva: World Health Organization, 2017. |
[13] |
郝晓刚, 王炜, 张幸, 等. 应用电子药盒辅助肺结核患者服药管理的实施情况研究. 中国防痨杂志, 2022, 44(1): 110-112. doi:10.19982/j.issn.1000-6621.20210339.
doi: 10.19982/j.issn.1000-6621.20210339 |
[14] |
景睿, 曹艳民, 杨一军, 等. 电子药盒和手机微信APP对肺结核患者督导服药管理的应用研究. 结核与肺部疾病杂志, 2020, 1(1): 96-99. doi:10.3969/j.issn.2096-8493.2020.01.020.
doi: 10.3969/j.issn.2096-8493.2020.01.020 |
[15] |
薛晓, 张东彦, 艾萍, 等. 肺结核患者电子药盒和微信小程序使用情况分析. 中国防痨杂志, 2022, 44(7): 704-710. doi:10.19982/j.issn.1000-6621.20220102.
doi: 10.19982/j.issn.1000-6621.20220102 |
[16] |
李智, 周惠, 陈晓军, 等. 基于数字技术的结核病患者管理方法研究进展. 中国防痨杂志, 2019, 41(9): 1015-1020. doi:10.3969/j.issn.1000-6621.2019.09.019.
doi: 10.3969/j.issn.1000-6621.2019.09.019 |
[17] | 桓世彤, 陈嵘, 刘小秋, 等. 电子药盒取药记录监测肺结核患者服药行为的可行性评估. 中国防痨杂志, 2012, 34(7): 419-424. |
[18] |
Liu X, Lewis JJ, Zhang H, et al. Effectiveness of Electronic Reminders to Improve Adherence in Tuberculosis Patients: A Cluster-Randomised Trail. PLoS Med, 2015, 12(9): e1001876. doi:10.1371/journal.pmed.1001876.
doi: 10.1371/journal.pmed.1001876 URL |
[19] |
Wu Z, Lu L, Li Y, et al. Effect of mobile health reminders on tuberculosis treatment outcomes in Shanghai, China: A prospective cohort study. Front Public Health, 2023, 11: 923319. doi:10.3389/fpubh.2023.923319.
doi: 10.3389/fpubh.2023.923319 URL |
[20] |
Liu X, Thompson J, Dong H, et al. Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial. Lancet Glob Health, 2023, 11(5): e693-e703. doi:10.1016/s2214-109x(23)00068-2.
doi: 10.1016/S2214-109X(23)00068-2 pmid: 37061308 |
[1] | Xu Liangrun, Yang Mingying, Guo Yingwu, Wang Yun, Xu Jingjing, Hou Juyan, Ma Yunhong. Effect of family collaborative care model in self-management of new smear-positive tuberculosis patients under the health belief model collaborative [J]. Chinese Journal of Antituberculosis, 2025, 47(2): 210-217. |
[2] | Zheng Hailun, Li Yamin, Sun Shanhua, He Xiaoxin. Analysis of influencing factors on treatment interruption in 317 pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 467-472. |
[3] | Zhang Yan, Wang Senlu, Rizwanguli Rehman, Liu Nianqiang, Wang Xinqi, Mao Hongkai, Wang Xiaomin, Cao Mingqin. Evaluation of the implementation effect of “Active Tuberculosis Screening+Full-Course Hospitalization” model for patient detection in Hotan Prefecture, Xinjiang Uygur Autonomous Region [J]. Chinese Journal of Antituberculosis, 2024, 46(2): 145-150. |
[4] | Bao Liangliang, Wang Xinqi, Zhang Yan, Cao Mingqin. Qualitative evaluation of the implementation status of tuberculosis prevention and control in Southern Xinjiang Uygur Autonomous Region: qualitative interviews based on grounded theories [J]. Chinese Journal of Antituberculosis, 2024, 46(2): 151-157. |
[5] | Zhang Han, Wang Lixia, Wei Yushi, Zhao Rui, Wang Xinqi, Liu Nianqiang, Wang Senlu. Evaluation of the application effect of digital therapeutics adherence technology in medication management of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(2): 158-164. |
[6] | Zheng Guangmin, Wang Ting, Zhang Danni, Lei Yu, Yang Jieying, Wu Guifeng, Du Yuhua, Xiao Xincai. Evaluation on the implementation effect of different tuberculosis prevention and control management models during the 13th Five-Year Plan period in Guangzhou [J]. Chinese Journal of Antituberculosis, 2024, 46(2): 199-205. |
[7] | Li Jianghong, Liu Fang, Yang Shumin, He Yujue, Ma Ling, Guo Qiang, Man Shijun. Investigation and analysis of diagnostic quality of pathogenic negative pulmonary tuberculosis in county level tuberculosis designated hospitals in Gansu Province [J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1478-1484. |
[8] | XUE Xiao, ZHANG Dong-yan, AI Ping, DENG Ling, CHEN Wei, HU Yuan-lian, JIA Xue-jiao, YANG Guo-liang, XIN Zhen-jiang, CHANG Li-jie. Analysis of the usage of electronic pillbox and WeChat App in pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 704-710. |
[9] | HU Yuan-lian, DENG Ling, AI Ping, JIA Xue-jiao, CHEN Wei, ZHANG Dong-yan, XUE Xiao, WU Qian-yu, XIE Jun-qing. Survey on the community treatment and management of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2022, 44(5): 473-477. |
[10] | TIAN Xiao-mei, LEI Juan, LIU Jing, LIU Guang-tian, PAN Li, LIU Tao, SHI Feng, WANG Xiao-lin. Analysis on the effect of diagnosis and treatment management of rifampicin-resistant pulmonary tuberculosis and financing mode in Ningxia [J]. Chinese Journal of Antituberculosis, 2021, 43(8): 772-777. |
[11] | FAN Jun, ZHANG Wen, ZHANG Ting, WANG Qing-ya, YU Ya, CHENG Jun. Analysis on characteristics of reported pulmonary tuberculosis among students in Chongqing from 2008 to 2019 [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 716-723. |
[12] | ZHOU Shuang, CHEN Nan, ZHU Kun, JIANG Hui, YANG Lei, DU Jian. Investigation of the experience of tuberculosis patients for follow up using the internet platform [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 398-403. |
[13] | KUANG Hao-bin, XIE Yu-hong, FENG Zhi-yu, QIN Hong-juan, LIAO Ya-yi, WANG Min, ZHANG Hong, YUANG Yuan, WU Di, CHEN Ze-ying, TAN Shou-yong. Analysis on the effect of management strategies for multidrug-resistant tuberculosis in Guangzhou from 2014-2019 [J]. Chinese Journal of Antituberculosis, 2021, 43(2): 113-118. |
[14] | YING Ruo-yan, HUANG Xiao-chen, WANG Jie, LIU Yi-dian, SHA Wei, YANG Hua. Analysis of the correlation between sensitivity of drugs in the treatment and the outcome of treatment in pulmonary tuberculosis patients retreated for the first time [J]. Chinese Journal of Antituberculosis, 2021, 43(10): 1001-1005. |
[15] | ZHOU Lin, LIU Er-yong, MENG Qing-lin, CHEN Ming-ting, ZHOU Xin-hua, GAO Wei-wei, LIN Ming-gui, XIE Ru-ming. Evaluation of the quality of pulmonary tuberculosis diagnosis after the implementation of the newly revised WS 288-2017 Diagnosis for pulmonary tuberculosis standards [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 910-915. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||